| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And CFO | SVP And CFO | CFO &Executive Vice President +1 more
3 companies
Dier Mardi is a CFO &Executive Vice President at RARE, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 37 sales. Those positions are worth an estimated $8.5M at current prices.
Our model assigns Dier Mardi a strong insider score of 70/100, based on 9 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +15.7%.
Dier Mardi's largest disclosed position is in MDGL as EVP And CFO, worth about $5.6M. The recent filings there lean toward selling, a net 9,557 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc. | EVP And CFO | Sell | 1,982 | $430.87 | $853,992.52 | -13.7% | +11.1% | - | |
| Mar 2, 2026 | MDGL Madrigal Pharmaceuticals, Inc. | EVP And CFO | Sell | 1,183 | $427.21 | $505,389.43 | -11.3% | - | - | |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | EVP And CFO | Sale+OE | 4,173 | $578.34 | $2,413,416.41 | -28.6% | -24.0% | - | |
| Mar 10, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And CFO | Sell | 258 | $323.04 | $83,344.32 | -2.4% | -14.9% | +31.5% | |
| Mar 3, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And CFO | Sell | 1,961 | $324.96 | $637,248.06 | -22.1% | -13.0% | +35.9% | |
| Oct 14, 2022 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 1,629 | $40.16 | $65,420.64 | -2.4% | +16.5% | -9.4% | |
| Oct 12, 2022 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 3,484 | $38.22 | $133,158.48 | -4.9% | +12.9% | -15.2% | |
| Mar 3, 2022 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 954 | $65.71 | $62,686.08 | -1.8% | -28.0% | -28.7% | |
| Oct 14, 2021 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 6,738 | $82.00 | $552,523.59 | -14.8% | -12.1% | -54.2% | |
| Sep 29, 2020 | PRLD Prelude Therapeutics Inc | Director | Buy | 10,000 | $19.00 | $190,000.00 | New | - | - |